Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Formulating paclitaxel in nanoparticles alters its disposition.
Globally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinoma.
Microvessels
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Formulating paclitaxel in nanoparticles alters its disposition.
Formulating paclitaxel in nanoparticles alters its disposition. Pharm Res. 2005 Jun; 22(6):867-74.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents, Phytogenic
Area Under Curve
Chemistry, Pharmaceutical
Chromatography, High Pressure Liquid
Ethanol
Female
Gelatin
Indicators and Reagents
Mice
Mice, Inbred BALB C
Mice, Nude
Microspheres
Paclitaxel
Polyethylene Glycols
Solvents
Tissue Distribution